NEW YORK, May 12, 2011 /PRNewswire/ -- Omni United, one of the fastest growing and most dynamic designers and manufacturers of tires in the world, has kicked off 'Mobilizing Hope' - a year-long partnership with The Breast Cancer Research Foundation (BCRF) starting this month.
In an industry first, Radar, the flagship tire brand of Singapore-based Omni United, will donate to The Breast Cancer Research Foundation $.25 per each Radar tire sold, with a committed minimum annual donation of $250,000. Omni United and Radar have enjoyed significant success and growth over the last few years and the company's current objective is to increase both awareness and funds to support the efforts of BCRF, with the goal of raising $1 million over the next year. 'Mobilizing Hope' will launch in the United States (in addition to Radar's other top markets including the United Kingdom) this month, with products benefiting BCRF available from more than 12,000 leading tire retailers serviced by TCI through May 2012. In addition, starting in August 2011 the full range of Radar tires will be available at 867 Sears Auto Centers across the US.
In addition to Radar's core products, which include the well-known Dimax R8 and the RPX800 UHP tire ranges, the program will include all of Radar's new ranges, such as the Centigrade RWX1, Radar's first winter tire, the Verenti R6 UHP range and the Renegade R5 mud terrain range, introduced at the end March. All the tires will have distinct labeling identifying the product as supportive of The Breast Cancer Research Foundation and Omni will make efforts over the next year to share BCRF's message.
"We at Omni-Radar believe that our company has a responsibility to the world beyond making a safe, durable, eco-friendly, and attractive tire for our customers," said G.S. Sareen, President and CEO of Omni United. "We are proud and excited to establish this relationship with The Breast Cancer Research Foundation, one of the most highly regarded not-for-profit organizations in the world. We are great fans of The Breast Cancer Research Foundation's work and dedication to the global cause of fighting breast cancer, a disease that has touched the lives of many in our communities. We admire BCRF's efficiency and relentless focus on funding the most cutting edge medical research to prevent and find a cure for breast cancer. We would like Radar Tires to leave a different type of mark in the world."
"The Breast Cancer Research Foundation is thrilled that Radar Tires chose to join us in our fight against breast cancer and to support our important work," said Evelyn Lauder, Founder and Chairman of The Breast Cancer Research Foundation.
"Radar Tires' 'Mobilizing Hope' campaign will not only help spread our message globally, but it has the potential to reach and impact men as well," said Myra Biblowit, President of The Breast Cancer Research Foundation. "This disease touches mothers, wives, sisters, daughters, and friends. Radar Tires' contributions will help fund innovative research that will advance the fight against breast cancer worldwide."
About Omni / Radar
Radar Tires is the flagship tire brand of Omni United, one of the fastest growing and most dynamic designers and manufacturers of tires in the world. It offers a complete range of passenger car, SUV, truck, bus, and farm tires, marketed under its own four brand names: Radar, Goodride, Roadlux and Corsa. Besides designing and manufacturing tires, Omni's unparalleled customer service and its state-of-the-art logistics and supply chain management systems are a cornerstone of its success.
Omni was founded in 2003 by Singapore-based entrepreneur G. S. Sareen. Although the company's headquarters are in Singapore, the USA is Omni's largest market, accounting for 70% of the company's business. Omni has 10 offices throughout the USA, including Florida, California, Michigan and Colorado. Other important fast growing markets are the United Kingdom, Spain, Germany, Middle East, South East Asia, Australia and Japan. Omni has been rated as the fastest growing company in Singapore and plans, again, to double its sales in 2011 over those of 2010. Designed in Singapore, the vast majority of Omni's products (including Radar Tires) are manufactured in modern, high-tech, state-of-the-art production facilities in Indonesia and China. All products are compliant with all the most stringent EU and USA tire regulations. For further information about Omni and Radar, please visit www.omni-united.com and www.radartires.com
About The Breast Cancer Research Foundation®
The Breast Cancer Research Foundation® was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit organization dedicated to funding innovative clinical and translational research at leading medical centers worldwide. In October 2010, BCRF awarded $33 million to 172 scientists across the United States, Canada, Latin America, Europe, the Middle East, and Australia. Currently, more than 90 cents of every dollar donated is directed to breast cancer research and awareness programs. With exceptionally low administrative costs, BCRF continues to be one of the most efficient organizations in the USA. BCRF has received 4 stars from Charity Navigator for nine consecutive years, outperforming 99% of more than 5,500 evaluated charities. Furthermore, the Foundation is consistently listed as an "A+" charity by The American Institute of Philanthropy. BCRF is the only breast cancer organization to receive AIP's top accolade, and is currently the only cancer organization to hold this ranking. For more information about BCRF, visit www.bcrfcure.org.
SOURCE Omni United
Advertisement
In an industry first, Radar, the flagship tire brand of Singapore-based Omni United, will donate to The Breast Cancer Research Foundation $.25 per each Radar tire sold, with a committed minimum annual donation of $250,000. Omni United and Radar have enjoyed significant success and growth over the last few years and the company's current objective is to increase both awareness and funds to support the efforts of BCRF, with the goal of raising $1 million over the next year. 'Mobilizing Hope' will launch in the United States (in addition to Radar's other top markets including the United Kingdom) this month, with products benefiting BCRF available from more than 12,000 leading tire retailers serviced by TCI through May 2012. In addition, starting in August 2011 the full range of Radar tires will be available at 867 Sears Auto Centers across the US.
Advertisement
In addition to Radar's core products, which include the well-known Dimax R8 and the RPX800 UHP tire ranges, the program will include all of Radar's new ranges, such as the Centigrade RWX1, Radar's first winter tire, the Verenti R6 UHP range and the Renegade R5 mud terrain range, introduced at the end March. All the tires will have distinct labeling identifying the product as supportive of The Breast Cancer Research Foundation and Omni will make efforts over the next year to share BCRF's message.
"We at Omni-Radar believe that our company has a responsibility to the world beyond making a safe, durable, eco-friendly, and attractive tire for our customers," said G.S. Sareen, President and CEO of Omni United. "We are proud and excited to establish this relationship with The Breast Cancer Research Foundation, one of the most highly regarded not-for-profit organizations in the world. We are great fans of The Breast Cancer Research Foundation's work and dedication to the global cause of fighting breast cancer, a disease that has touched the lives of many in our communities. We admire BCRF's efficiency and relentless focus on funding the most cutting edge medical research to prevent and find a cure for breast cancer. We would like Radar Tires to leave a different type of mark in the world."
"The Breast Cancer Research Foundation is thrilled that Radar Tires chose to join us in our fight against breast cancer and to support our important work," said Evelyn Lauder, Founder and Chairman of The Breast Cancer Research Foundation.
"Radar Tires' 'Mobilizing Hope' campaign will not only help spread our message globally, but it has the potential to reach and impact men as well," said Myra Biblowit, President of The Breast Cancer Research Foundation. "This disease touches mothers, wives, sisters, daughters, and friends. Radar Tires' contributions will help fund innovative research that will advance the fight against breast cancer worldwide."
About Omni / Radar
Radar Tires is the flagship tire brand of Omni United, one of the fastest growing and most dynamic designers and manufacturers of tires in the world. It offers a complete range of passenger car, SUV, truck, bus, and farm tires, marketed under its own four brand names: Radar, Goodride, Roadlux and Corsa. Besides designing and manufacturing tires, Omni's unparalleled customer service and its state-of-the-art logistics and supply chain management systems are a cornerstone of its success.
Omni was founded in 2003 by Singapore-based entrepreneur G. S. Sareen. Although the company's headquarters are in Singapore, the USA is Omni's largest market, accounting for 70% of the company's business. Omni has 10 offices throughout the USA, including Florida, California, Michigan and Colorado. Other important fast growing markets are the United Kingdom, Spain, Germany, Middle East, South East Asia, Australia and Japan. Omni has been rated as the fastest growing company in Singapore and plans, again, to double its sales in 2011 over those of 2010. Designed in Singapore, the vast majority of Omni's products (including Radar Tires) are manufactured in modern, high-tech, state-of-the-art production facilities in Indonesia and China. All products are compliant with all the most stringent EU and USA tire regulations. For further information about Omni and Radar, please visit www.omni-united.com and www.radartires.com
About The Breast Cancer Research Foundation®
The Breast Cancer Research Foundation® was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit organization dedicated to funding innovative clinical and translational research at leading medical centers worldwide. In October 2010, BCRF awarded $33 million to 172 scientists across the United States, Canada, Latin America, Europe, the Middle East, and Australia. Currently, more than 90 cents of every dollar donated is directed to breast cancer research and awareness programs. With exceptionally low administrative costs, BCRF continues to be one of the most efficient organizations in the USA. BCRF has received 4 stars from Charity Navigator for nine consecutive years, outperforming 99% of more than 5,500 evaluated charities. Furthermore, the Foundation is consistently listed as an "A+" charity by The American Institute of Philanthropy. BCRF is the only breast cancer organization to receive AIP's top accolade, and is currently the only cancer organization to hold this ranking. For more information about BCRF, visit www.bcrfcure.org.
SOURCE Omni United
